KPV for Gut Inflammation: IBD, Colitis, and Clinical Evidence
How the KPV tripeptide reduces gut inflammation. NF-kB inhibition, PepT1 uptake, IBD and colitis evidence, oral dosing, and clinical observations.
Peptide Therapy
Emerging EvidenceKPV
Alpha-MSH fragment for NF-kB inhibition with preferential uptake in inflamed gut tissue.
